Fatty Acids Supplement Market (2026)

MARKET INSIGHTS

Global fatty acids supplement market was valued at USD 4.87 billion in 2025. The market is projected to grow to USD 5.25 billion in 2026 and reach USD 10.5 billion by 2034, exhibiting a CAGR of 9.5% during the forecast period.

Fatty acids supplements are nutritional products containing essential lipids that the human body cannot synthesize, primarily omega-3 and omega-6 varieties. These compounds play critical roles in cardiovascular health, brain function, and inflammatory response regulation. Key product forms include fish oil capsules, algae-based supplements, flaxseed oil, and blended formulations.

Fatty Acids Supplement Market – View in Detailed Research Report

Top 10 Companies in the Fatty Acids Supplement Market (2026)

1. DSM (Netherlands)
   Headquarters: Heerlen, Netherlands
   Key Offering: High‑purity omega‑3 oils, algae‑derived DHA, clinical‑grade API.
   DSM has been a pioneer in sustainable sourcing, achieving full traceability from fish farms to finished products. Their R&D team has developed phospholipid‑enriched omega‑3 formulations that enhance bioavailability for cardiovascular and cognitive health.
   Sustainability & Growth Initiatives:
   • Certified sustainable fisheries and algae farms.
   • Carbon‑neutral manufacturing by 2030.
   • Investment in next‑generation bio‑refinery technology.
2. BASF (Germany)
   Headquarters: Ludwigshafen, Germany
   Key Offering: Marine and plant‑based omega‑3 oils, fortified functional foods, and infant formula ingredients.
   BASF leverages its global supply chain to deliver consistent quality and high concentrations of EPA and DHA. Their proprietary encapsulation technology protects against oxidation and fishy aftertaste.
   Sustainability & Growth Initiatives:
   • Zero‑waste production facilities.
   • Partnerships with certified sustainable fisheries.
   • Development of plant‑based omega‑3 blends for vegan consumers.
3. Croda International (UK)
   Headquarters: London, United Kingdom
   Key Offering: Premium lipid ingredients for nutraceuticals, functional foods, and pharmaceuticals.
   Croda’s acquisition of Innovotech has expanded its portfolio to include high‑concentration omega‑3 APIs and plant‑based oils, enabling them to serve both consumer and clinical markets.
   Sustainability & Growth Initiatives:
   • ISO 14001 environmental management.
   • Carbon‑reduction targets across the supply chain.
   • Investment in algae‑derived DHA production.
4. Clover Corporation (Australia)
   Headquarters: Melbourne, Australia
   Key Offering: Infant formula ingredients, marine‑derived proteins, and omega‑3 oils.
   Clover focuses on high‑quality raw materials for early‑life nutrition, ensuring strict quality controls and traceability from fish farms to finished products.
   Sustainability & Growth Initiatives:
   • Fish‑farm certification (MSC, ASC).
   • Water‑efficient processing technologies.
   • Research on sustainable protein sourcing.
5. Omega Protein Corporation (USA)
   Headquarters: Chicago, Illinois, USA
   Key Offering: Marine‑derived protein powders, omega‑3 enriched supplements, and functional food ingredients.
   Omega Protein integrates protein and omega‑3 delivery, targeting athletes and health‑conscious consumers. Their proprietary micro‑encapsulation preserves flavor and enhances absorption.
   Sustainability & Growth Initiatives:
   • Renewable energy usage in production.
   • Recyclable packaging solutions.
   • Partnerships with sustainable fisheries.
6. Natrol (USA)
   Headquarters: Overland Park, Kansas, USA
   Key Offering: Consumer‑grade fish oil capsules, algae‑based omega‑3 supplements, and vitamin‑enriched blends.
   Natrol emphasizes third‑party testing for purity and potency, building trust among health‑conscious consumers and healthcare professionals.
   Sustainability & Growth Initiatives:
   • Eco‑friendly bottle materials.
   • Transparency in ingredient sourcing.
   • Community health education programs.
7. Orkla Health (Norway)
   Headquarters: Oslo, Norway
   Key Offering: Premium fish oil and algae‑based supplements, fortified functional foods.
   Orkla Health leverages its Scandinavian heritage to focus on clean labeling and high‑quality ingredients, appealing to premium market segments.
   Sustainability & Growth Initiatives:
   • Sustainable fisheries certification.
   • Carbon‑neutral logistics.
   • Investments in plant‑based omega‑3 alternatives.
8. BIOCARE (UK)
   Headquarters: Birmingham, United Kingdom
   Key Offering: Clinical‑grade omega‑3 APIs, lipid‑based drug delivery systems, and research‑grade raw materials.
   BIOCARE serves pharmaceutical and nutraceutical markets, focusing on stringent quality standards and clinical validation of health claims.
   Sustainability & Growth Initiatives:
   • Zero‑waste production.
   • Renewable energy sourcing.
   • Research on algae‑derived DHA.
9. Epax Norway (Norway)
   Headquarters: Oslo, Norway
   Key Offering: Ultra‑pure, high‑concentration omega‑3 API oils for pharmaceutical and nutraceutical use.
   Epax’s proprietary purification process removes contaminants, ensuring high potency and safety for therapeutic applications.
   Sustainability & Growth Initiatives:
   • Fish‑farm sustainability certification.
   • Carbon‑neutral manufacturing.
   • Investment in alternative algae sources.
10. VitaOmega (USA)
    Headquarters: San Diego, California, USA
    Key Offering: Plant‑based omega‑3 blends (flaxseed, chia, hemp) and algae‑derived DHA for vegan and vegetarian consumers.
    VitaOmega focuses on clean‑label, sustainably sourced ingredients, addressing the growing demand for vegan nutrition supplements.
    Sustainability & Growth Initiatives:
    • Certified organic sourcing.
    • Recyclable packaging.
    • Carbon‑offset programs.

Download FREE Sample Report: Fatty Acids Supplement Market – View in Detailed Research Report

Fatty Acids Supplement Market – View in Detailed Research Report

Outlook

Global fatty acids supplement market is poised for robust growth, driven by escalating health consciousness, rising chronic disease prevalence, and expanding geriatric populations. The shift toward plant‑based and sustainably sourced products, coupled with regulatory support for health claims, is creating new market segments and opportunities for differentiation.

Future Trends

• Rapid adoption of algae‑derived DHA and other plant‑based omega‑3 sources.
• Integration of omega‑3s into functional foods, beverages, and fortified products.
• Enhanced bioavailability through micro‑encapsulation and phospholipid formulations.
• Digitalization of supply chains and real‑time quality monitoring.
• Regulatory frameworks evolving to support evidence‑based health claims.